Life of psi: How full-length HIV-1 RNAs become packaged genomes in the viral particles

Virology

Volumn 454-455, Issue 1, 2014, Pages 362-370

  Kuzembayeva, Malika ^a   Dilley, Kari ^a   Sardo, Luca ^a   Hu, Wei Shau ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Full length RNA; Gag; HIV 1; Retrovirus; Rev; RNA dimerization; RNA export; RNA packaging; RNA transcription and processing; RRE; Virus assembly

Indexed keywords

CIS ACTING ELEMENT; GAG PROTEIN; POL PROTEIN; REV PROTEIN; TRANS ACTING FACTOR; VIRUS RNA;

BIOGENESIS; DIMERIZATION; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR DYNAMICS; NONHUMAN; NUCLEIC ACID STRUCTURE, METABOLISM AND FUNCTION; NUCLEIC ACID TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; REVIEW; RNA EXPORT; RNA PACKAGING; RNA TRANSCRIPTION; RNA TRANSLATION; RNA TRANSPORT; VIRUS GENOME; VIRUS PARTICLE; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

FULL-LENGTH RNA; GAG; HIV-1; RETROVIRUS; REV; RNA DIMERIZATION; RNA EXPORT; RNA PACKAGING; RNA TRANSCRIPTION AND PROCESSING; RRE; VIRUS ASSEMBLY;

HIV-1; RNA, VIRAL; VIRION; VIRUS ASSEMBLY;

EID: 84897959539     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.01.019     Document Type: Review

References (161)

1. Abbink T.E.M., Berkhout B. A novel long distance base-pairing interaction in human immunodeficiency virus type 1 RNA occludes the Gag start codon. J. Biol. Chem. 2003, 278:11601-11611.
2. Adam M.A., Miller A.D. Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions. J. Virol. 1988, 62:3802-3806.
3. Adams M., Sharmeen L., Kimpton J., Romeo J.M., Garcia J.V., Peterlin B.M., Groudine M., Emerman M. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:3862-3866.
4. Aldovini A., Young R.A. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J Virol. 1990, 64:1920-1926.
5. Awang G., Sen D. Mode of dimerization of HIV-1 genomic RNA. Biochemistry (Mosc.) 1993, 32:11453-11457.
6. Battiste J.L., Mao H., Rao N.S., Tan R., Muhandiram D.R., Kay L.E., Frankel A.D., Williamson J.R. Alpha helix-RNA major groove recognition in an HIV-1 rev peptide-RRE RNA complex. Science 1996, 273:1547-1551.
7. Baudin F., Marquet R., Isel C., Darlix J.L., Ehresmann B., Ehresmann C. Functional sites in the 5' region of human immunodeficiency virus type 1 RNA form defined structural domains. J. Mol. Biol. 1993, 229:382-397.
8. Bender W., Chien Y.H., Chattopadhyay S., Vogt P.K., Gardner M.B., Davidson N. High-molecular-weight RNAs of AKR, NZB, and wild mouse viruses and avian reticuloendotheliosis virus all have similar dimer structures. J. Virol. 1978, 25:888-896.
9. Bender W., Davidson N. Mapping of poly(A) sequences in the electron microscope reveals unusual structure of type C oncornavirus RNA molecules. Cell 1976, 7:595-607.
10. Berkhout B., van Wamel J.L. The leader of the HIV-1 RNA genome forms a compactly folded tertiary structure. RNA 2000, 6:282-295.
11. Berkhout B., Vastenhouw N.L., Klasens B.I., Huthoff H. Structural features in the HIV-1 repeat region facilitate strand transfer during reverse transcription. RNA N. Y. 2001, 7:1097-1114.
12. Berkowitz R.D., Luban J., Goff S.P. Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays. J. Virol. 1993, 67:7190-7200.
13. Berkowitz R.D., Ohagen A., Hoglund S., Goff S.P. Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo. J Virol. 1995, 69:6445-6456.
14. Bernad R., van der Velde H., Fornerod M., Pickersgill H. Nup358/RanBP2 attaches to the nuclear pore complex via association with Nup88 and Nup214/CAN and plays a supporting role in CRM1-mediated nuclear protein export. Mol. Cell. Biol. 2004, 24:2373-2384.
15. Bieniasz P.D., Grdina T.A., Bogerd H.P., Cullen B.R. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 1998, 17:7056-7065.
16. Bray M., Prasad S., Dubay J.W., Hunter E., Jeang K.T., Rekosh D., Hammarskjöld M.L. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc. Natl. Acad. Sci. 1994, 91:1256-1260.
17. Buchschacher G.L., Panganiban A.T. Human immunodeficiency virus vectors for inducible expression of foreign genes. J. Virol. 1992, 66:2731-2739.
18. Butsch M., Boris-Lawrie K. Translation is not required To generate virion precursor RNA in human immunodeficiency virus type 1-infected T cells. J. Virol. 2000, 74:11531-11537.
19. Cai M., Huang Y., Craigie R., Clore G.M. Structural basis of the association of HIV-1 matrix protein with DNA. PloS One 2010, 5:e15675.
20. Chen J., Nikolaitchik O., Singh J., Wright A., Bencsics C.E., Coffin J.M., Ni N., Lockett S., Pathak V.K., Hu W.S. High efficiency of HIV-1 genomic RNA packaging and heterozygote formation revealed by single virion analysis. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:13535-13540.
21. Chien Y.H., Deng C.T., Chandler P., Davidson N. A method for the isolation of segments from the 5' ends of retrovirus RNA. Anal. Biochem. 1980, 102:281-287.
22. Chin M.P., Rhodes T.D., Chen J., Fu W., Hu W.S. Identification of a major restriction in HIV-1 intersubtype recombination. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:9002-9007.
23. Chukkapalli V., Hogue I.B., Boyko V., Hu W.-S., Ono A. Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient gag membrane binding. J. Virol. 2008, 82:2405-2417.
24. Chukkapalli V., Oh S.J., Ono A. Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:1600-1605.
25. Clavel F., Orenstein J.M. A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology. J. Virol. 1990, 64:5230-5234.
26. Clever J., Sassetti C., Parslow T.G. RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1. J. Virol. 1995, 69:2101-2109.
27. Clever J., Sassetti C., Parslow T.G. RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1. J. Virol. 1995, 69:2101-2109.
28. Clever J.L., Eckstein D.A., Parslow T.G. Genetic dissociation of the encapsidation and reverse transcription functions in the 5' R region of human immunodeficiency virus type 1. J. Virol. 1999, 73:101-109.
29. Clever J.L., Wong M.L., Parslow T.G. Requirements for kissing-loop-mediated dimerization of human immunodeficiency virus RNA. J. Virol. 1996, 70:5902-5908.
30. Coffin J.M. Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses. J. Gen. Virol. 1979, 42:1-26.
31. Cold Spring Harbor Laboratory Press 1997, J.M. Coffin, S.H. Hughes, H.E. Varmus (Eds.).
32. Cook K.S., Fisk G.J., Hauber J., Usman N., Daly T.J., Rusche J.R. Characterization of HIV-1 REV protein: binding stoichiometry and minimal RNA substrate. Nucleic Acids Res. 1991, 19:1577-1583.
33. Cullen B.R. Retroviruses as model systems for the study of nuclear RNA export pathways. Virology 1998, 249:203-210.
34. Cullen B.R. Nuclear mRNA export: insights from virology. Trends Biochem. Sci. 2003, 28:419-424.
35. Daelemans D., Afonina E., Nilsson J., Werner G., Kjems J., De Clercq E., Pavlakis G.N., Vandamme A.-M. A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export. Proc. Natl. Acad. Sci. U. S. A 2002, 99:14440-14445.
36. Damgaard C.K., Andersen E.S., Knudsen B., Gorodkin J., Kjems J. RNA interactions in the 5' region of the HIV-1 genome. J. Mol. Biol. 2004, 336:369-379.
37. Darlix J.L., Gabus C., Nugeyre M.T., Clavel F., Barre-Sinoussi F. Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. J. Mol. Biol. 1990, 216:689-699.
38. Das A.T., Harwig A., Vrolijk M.M., Berkhout B. The TAR hairpin of human immunodeficiency virus type 1 can be deleted when not required for Tat-mediated activation of transcription. J. Virol. 2007, 81:7742-7748.
39. Das A.T., Klaver B., Berkhout B. The 5' and 3' TAR elements of human immunodeficiency virus exert effects at several points in the virus life cycle. J. Virol. 1998, 72:9217-9223.
40. Daugherty M.D., Booth D.S., Jayaraman B., Cheng Y., Frankel A.D. HIV Rev response element (RRE) directs assembly of the Rev homooligomer into discrete asymmetric complexes. Proc. Natl. Acad. Sci. U. S. A 2010, 107:12481-12486.
41. Daugherty M.D., Liu B., Frankel A.D. Structural basis for cooperative RNA binding and export complex assembly by HIV Rev. Nat. Struct. Mol. Biol. 2010, 17:1337-1342.
42. De Guzman R.N., Wu Z.R., Stalling C.C., Pappalardo L., Borer P.N., Summers M.F. Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element. Science 1998, 279:384-388.
43. DiMattia M.A., Watts N.R., Stahl S.J., Rader C., Wingfield P.T., Stuart D.I., Steven A.C., Grimes J.M. Implications of the HIV-1 Rev dimer structure at 3.2A resolution for multimeric binding to the Rev response element. Proc. Natl. Acad. Sci. U. S. A 2010, 107:5810-5814.
44. Dorfman T., Luban J., Goff S.P., Haseltine W.A., Gottlinger H.G. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 1993, 67:6159-6169.
45. Dorman N., Lever A. Comparison of viral genomic RNA sorting mechanisms in human immunodeficiency virus type 1 (HIV-1), HIV-2, and Moloney murine leukemia virus. J. Virol. 2000, 74:11413-11417.
46. Dube S., Kung H.J., Bender W., Davidson N., Ostertag W. Size, subunit composition, and secondary structure of the Friend virus genome. J. Virol. 1976, 20:264-272.
47. Edgcomb S.P., Carmel A.B., Naji S., Ambrus-Aikelin G., Reyes J.R., Saphire A.C.S., Gerace L., Williamson J.R. DDX1 is an RNA-dependent ATPase involved in HIV-1 Rev function and virus replication. J. Mol. Biol. 2012, 415:61-74.
48. Elinav H., Wu Y., Coskun A., Hryckiewicz K., Kemler I., Hu Y., Rogers H., Hao B., Ben Mamoun C., Poeschla E., Sutton R. Human CRM1 augments production of infectious human and feline immunodeficiency viruses from murine cells. J. Virol. 2012, 86:12053-12068.
49. Fackler O.T., Peterlin B.M., Weis K. Lessons from HIV: movement of macromolecules inside the cell. Curr. Mol. Med. 2001, 1:1-7.
50. Fang J., Kubota S., Yang B., Zhou N., Zhang H., Godbout R., Pomerantz R.J. A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev. Virology 2004, 330:471-480.
51. Fang X., Wang J., O'Carroll I.P., Mitchell M., Zuo X., Wang Y., Yu P., Liu Y., Rausch J.W., Dyba M.A., Kjems J., Schwieters C.D., Seifert S., Winans R.E., Watts N.R., Stahl S.J., Wingfield P.T., Byrd R.A., Le Grice S.F.J., Rein A., Wang Y.-X. An Unusual Topological Structure of the HIV-1 Rev Response Element. Cell 2013, 155:594-605.
52. Felber B.K., Hadzopoulou-Cladaras M., Cladaras C., Copeland T., Pavlakis G.N. rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. U. S. A 1989, 86:1495-1499.
53. Fornerod M., Ohno M., Yoshida M., Mattaj I.W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 1997, 90:1051-1060.
54. Freed E.O., Martin M.A. HIVs and Their Replication. Field[U+05F3]s Virology 2013, 1502-1560. Lippincott, Williams, and Wilkins.
55. Gaynor R.B. Regulation of HIV-1 gene expression by the transactivator protein Tat. Curr. Top. Microbiol. Immunol. 1995, 193:51-77.
56. Gaynor R.B. Regulation of HIV-1 gene expression by the transactivator protein Tat. Curr. Top. Microbiol. Immunol. 1995, 193:51-77.
57. Gordon H., Ajamian L., Valiente-Echeverrìa F., Lévesque K., Rigby W.F., Mouland A.J. Depletion of hnRNP A2/B1 overrides the nuclear retention of the HIV-1 genomic RNA. RNA Biol. 2013, 10.
58. Gorelick R.J., Nigida S.M., Bess J.W., Arthur L.O., Henderson L.E., Rein A. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J. Virol. 1990, 64:3207-3211.
59. Grüter P., Tabernero C., von Kobbe C., Schmitt C., Saavedra C., Bachi A., Wilm M., Felber B.K., Izaurralde E. TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus. Mol. Cell 1998, 1:649-659.
60. Hadzopoulou-Cladaras M., Felber B.K., Cladaras C., Athanassopoulos A., Tse A., Pavlakis G.N. The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. J. Virol. 1989, 63:1265-1274.
61. Hammarskjold M.-L., Rekosh D. A Long-Awaited Structure Is Rev-ealed. Viruses 2011, 3:484-492.
62. Harrison G.P., Lever A.M. The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure. J. Virol. 1992, 66:4144-4153.
63. Hauber J., Cullen B.R. Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat. J. Virol. 1988, 62:673-679.
64. Hayashi T., Shioda T., Iwakura Y., Shibuta H. RNA packaging signal of human immunodeficiency virus type 1. Virology 1992, 188:590-599.
65. Heng X., Kharytonchyk S., Garcia E.L., Lu K., Divakaruni S.S., LaCotti C., Edme K., Telesnitsky A., Summers M.F. Identification of a minimal region of the HIV-1 5'-leader required for RNA dimerization, NC binding, and packaging. J. Mol. Biol. 2012, 417:224-239.
66. Hibbert C.S., Mirro J., Rein A. mRNA molecules containing murine leukemia virus packaging signals are encapsidated as dimers. J. Virol. 2004, 78:10927-10938.
67. Hoglund S., Ohagen A., Goncalves J., Panganiban A.T., Gabuzda D. Ultrastructure of HIV-1 genomic RNA. Virology 1997, 233:271-279.
68. Hu W.S., Temin H.M. Retroviral recombination and reverse transcription. Science 1990, 250:1227-1233.
69. Hu W.S., Temin H.M. Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc. Natl. Acad. Sci. U. S. A 1990, 87:1556-1560.
70. Hu W.S., Temin H.M. Effect of gamma radiation on retroviral recombination. J. Virol. 1992, 66:4457-4463.
71. Huang Y., Steitz J.A. SRprises along a Messenger[U+05F3]s Journey. Mol. Cell 2005, 17:613-615.
72. Huthoff H., Berkhout B. Two alternating structures of the HIV-1 leader RNA. RNA. 2001, 7:143-157.
73. Huthoff H., Berkhout B. Mutations in the TAR hairpin affect the equilibrium between alternative conformations of the HIV-1 leader RNA. Nucleic. Acids. Res. 2001, 29:2594-2600.
74. Huthoff H., Girard F., Wijmenga S.S., Berkhout B. Evidence for a base triple in the free HIV-1 TAR RNA. RNA N. Y. 2004, 10:412-423.
75. Ivanchenko S., Godinez W.J., Lampe M., Kräusslich H.-G., Eils R., Rohr K., Bräuchle C., Müller B., Lamb D.C. Dynamics of HIV-1 assembly and release. PLoS Pathog. 2009, 5:e1000652.
76. Jin J., Sturgeon T., Weisz O.A., Mothes W., Montelaro R.C. HIV-1 matrix dependent membrane targeting is regulated by Gag mRNA trafficking. PloS One 2009, 4:e6551.
77. Jones K.A., Peterlin B.M. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 1994, 63:717-743.
78. Jouvenet N., Bieniasz P.D., Simon S.M. Imaging the biogenesis of individual HIV-1 virions in live cells. Nature 2008, 454:236-240.
79. Jouvenet N., Neil S.J.D., Bess C., Johnson M.C., Virgen C.A., Simon S.M., Bieniasz P.D. Plasma membrane is the site of productive HIV-1 particle assembly. PLoS Biol. 2006, 4:e435.
80. Jouvenet N., Simon S.M., Bieniasz P.D. Imaging the interaction of HIV-1 genomes and Gag during assembly of individual viral particles. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:19114-19119.
81. Kemler I., Meehan A., Poeschla E.M. Live-cell coimaging of the genomic RNAs and Gag proteins of two lentiviruses. J. Virol. 2010, 84:6352-6366.
82. Kieken F., Paquet F., Brule F., Paoletti J., Lancelot G. A new NMR solution structure of the SL1 HIV-1Lai loop-loop dimer. Nucleic. Acids. Res. 2006, 34:343-352.
83. Kim S.Y., Byrn R., Groopman J., Baltimore D. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J. Virol. 1989, 63:3708-3713.
84. Kjems J., Frankel A.D., Sharp P.A. Specific regulation of mRNA splicing in vitro by a peptide from HIV-1Rev. Cell 1991, 67:169-178.
85. Kudo N., Matsumori N., Taoka H., Fujiwara D., Schreiner E.P., Wolff B., Yoshida M., Horinouchi S. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:9112-9117.
86. Kula A., Guerra J., Knezevich A., Kleva D., Myers M.P., Marcello A. Characterization of the HIV-1 RNA associated proteome identifies Matrin 3as a nuclear cofactor of Rev function. Retrovirology 2011, 8:60.
87. Kutluay S.B., Bieniasz P.D. Analysis of the initiating events in HIV-1 particle assembly and genome packaging. PLoS Pathog. 2010, 6:e1001200.
88. Laughrea M., Jetté L. A 19-nucleotide sequence upstream of the 5' major splice donor is part of the dimerization domain of human immunodeficiency virus 1 genomic RNA. Biochemistry (Mosc.) 1994, 33:13464-13474.
89. Lehmann M., Milev M.P., Abrahamyan L., Yao X.-J., Pante N., Mouland A.J. Intracellular transport of human immunodeficiency virus type 1 genomic RNA and viral production are dependent on dynein motor function and late endosome positioning. J. Biol. Chem. 2009, 284:14572-14585.
90. Lei E.P., Silver P.A. Intron status and 3'-end formation control cotranscriptional export of mRNA. Genes Dev. 2002, 16:2761-2766.
91. Lever A., Gottlinger H., Haseltine W., Sodroski J. Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J. Virol. 1989, 63:4085-4087.
92. Levin J.G., Grimley P.M., Ramseur J.M., Berezesky I.K. Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J. Virol. 1974, 14:152-161.
93. Levin J.G., Rosenak M.J. Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: evidence for persistence of viral messenger RNA. Proc. Natl. Acad. Sci. U. S. A. 1976, 73:1154-1158.
94. Libri D., Dower K., Boulay J., Thomsen R., Rosbash M., Jensen T.H. Interactions between mRNA export commitment, 3'-end quality control, and nuclear degradation. Mol. Cell. Biol. 2002, 22:8254-8266.
95. Lochrie M.A., Waugh S., Pratt D.G., Clever J., Parslow T.G., Polisky B. In vitro selection of RNAs that bind to the human immunodeficiency virus type-1 gag polyprotein. Nucleic Acids Res. 1997, 25:2902-2910.
96. Lu K., Heng X., Garyu L., Monti S., Garcia E.L., Kharytonchyk S., Dorjsuren B., Kulandaivel G., Jones S., Hiremath A., Divakaruni S.S., LaCotti C., Barton S., Tummillo D., Hosic A., Edme K., Albrecht S., Telesnitsky A., Summers M.F. NMR detection of structures in the HIV-1 5'-leader RNA that regulate genome packaging. Science 2011, 334:242-245.
97. Luban J., Goff S.P. Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein. J. Virol. 1991, 65:3203-3212.
98. Luban J., Goff S.P. Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA. J. Virol. 1994, 68:3784-3793.
99. Ma J., Rong L., Zhou Y., Roy B.B., Lu J., Abrahamyan L., Mouland A.J., Pan Q., Liang C. The requirement of the DEAD-box protein DDX24 for the packaging of human immunodeficiency virus type 1 RNA. Virology 2008, 375:253-264.
100. Malim M.H., Böhnlein S., Hauber J., Cullen B.R. Functional dissection of the HIV-1 Rev trans-activator - derivation of a trans-dominant repressor of Rev function. Cell 1989, 58:205-214.
101. Malim M.H., Hauber J., Fenrick R., Cullen B.R. Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes. Nature 1988, 335:181-183.
102. Malim M.H., Hauber J., Le S.Y., Maizel J.V., Cullen B.R. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 1989, 338:254-257.
103. Malim M.H., Tiley L.S., McCarn D.F., Rusche J.R., Hauber J., Cullen B.R. HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell 1990, 60:675-683.
104. Maniatis T., Reed R. An extensive network of coupling among gene expression machines. Nature 2002, 416:499-506.
105. Mann D.A., Mikaélian I., Zemmel R.W., Green S.M., Lowe A.D., Kimura T., Singh M., Butler P.J., Gait M.J., Karn J. A molecular rheostat. Co-operative rev binding to stem I of the rev-response element modulates human immunodeficiency virus type-1 late gene expression. J. Mol. Biol. 1994, 241:193-207.
106. Mariani R., Rutter G., Harris M.E., Hope T.J., Kräusslich H.G., Landau N.R. A block to human immunodeficiency virus type 1 assembly in murine cells. J. Virol. 2000, 74:3859-3870.
107. Marquet R., Baudin F., Gabus C., Darlix J.L., Mougel M., Ehresmann C., Ehresmann B. Dimerization of human immunodeficiency virus (type 1) RNA: stimulation by cations and possible mechanism. Nucleic Acids Res. 1991, 19:2349-2357.
108. McBride M.S., Schwartz M.D., Panganiban A.T. Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation. J. Virol. 1997, 71:4544-4554.
109. Molle D., Segura-Morales C., Camus G., Berlioz-Torrent C., Kjems J., Basyuk E., Bertrand E. Endosomal trafficking of HIV-1 gag and genomic RNAs regulates viral egress. J. Biol. Chem. 2009, 284:19727-19743.
110. Moore M.D., Fu W., Nikolaitchik O., Chen J., Ptak R.G., Hu W.S. Dimer initiation signal of human immunodeficiency virus type 1: its role in partner selection during RNA copackaging and its effects on recombination. J. Virol. 2007, 81:4002-4011.
111. Moore M.D., Nikolaitchik O.A., Chen J., Hammarskjold M.L., Rekosh D., Hu W.S. Probing the HIV-1 genomic RNA trafficking pathway and dimerization by genetic recombination and single virion analyses. PLoS Pathog. 2009, 5:e1000627.
112. Moore M.J., Proudfoot N.J. Pre-mRNA processing reaches back totranscription and ahead to translation. Cell 2009, 136:688-700.
113. Muriaux D., Girard P.M., Bonnet-Mathoniere B., Paoletti J. Dimerization of HIV-1Lai RNA at low ionic strength. An autocomplementary sequence in the 5' leader region is evidenced by an antisense oligonucleotide. J. Biol. Chem. 1995, 270:8209-8216.
114. Murti K.G., Bondurant M., Tereba A. Secondary structural features in the 70S RNAs of Moloney murine leukemia and Rous sarcoma viruses as observed by electron microscopy. J. Virol. 1981, 37:411-419.
115. Nagai-Fukataki M., Ohashi T., Hashimoto I., Kimura T., Hakata Y., Shida H. Nuclear and cytoplasmic effects of human CRM1 on HIV-1 production in rat cells. Genes Cells Devot. Mol. Cell. Mech. 2011, 16:203-216.
116. Naji S., Ambrus G., Cimermančič P., Reyes J.R., Johnson J.R., Filbrandt R., Huber M.D., Vesely P., Krogan N.J., Yates J.R., Saphire A.C., Gerace L. Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production. Mol. Cell. Proteomics MCP 2012, 11. M111.015313-1-M111.015313-14.
117. Nakielny S., Dreyfuss G. Transport of proteins and RNAs in and out of the nucleus. Cell 1999, 99:677-690.
118. Neville M., Stutz F., Lee L., Davis L.I., Rosbash M. The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export. Curr. Biol. 1997, 7:767-775.
119. Nguyen D.H., Hildreth J.E. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 2000, 74:3264-3272.
120. Nikolaitchik O., Rhodes T.D., Ott D., Hu W.-S. Effects of mutations in the human immunodeficiency virus type 1 Gag gene on RNA packaging and recombination. J. Virol. 2006, 80:4691-4697.
121. Nikolaitchik O.A., Dilley K.A., Fu W., Gorelick R.J., Tai S.-H.S., Soheilian F., Ptak R.G., Nagashima K., Pathak V.K., Hu W.-S. Dimeric RNA recognition regulates HIV-1 genome packaging. PLoS Pathog. 2013, 9:e1003249.
122. Okada H., Zhang X., Ben Fofana I., Nagai M., Suzuki H., Ohashi T., Shida H. Synergistic effect of human CycT1 and CRM1 on HIV-1 propagation in rat T cells and macrophages. Retrovirology 2009, 6:43.
123. Ono A. HIV-1 assembly at the plasma membrane: Gag trafficking and localization. Future Virol. 2009, 4:241-257.
124. Ono A. HIV-1 assembly at the plasma membrane. Vaccine 2010, 28(Suppl. 2):B55-B59.
125. Ono A., Freed E.O. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:13925-13930.
126. Ooms M., Huthoff H., Russell R., Liang C., Berkhout B. A riboswitch regulates RNA dimerization and packaging in human immunodeficiency virus type 1 virions. J. Virol. 2004, 78:10814-10819.
127. Otero G.C., Harris M.E., Donello J.E., Hope T.J. Leptomycin B inhibits equine infectious anemia virus Rev and feline immunodeficiency virus rev function but not the function of the hepatitis B virus posttranscriptional regulatory element. J. Virol. 1998, 72:7593-7597.
128. Paillart J.C., Marquet R., Skripkin E., Ehresmann B., Ehresmann C. Mutational analysis of the bipartite dimer linkage structure of human immunodeficiency virus type 1 genomic RNA. J. Biol. Chem. 1994, 269:27486-27493.
129. Paillart J.C., Westhof E., Ehresmann C., Ehresmann B., Marquet R. Non-canonical interactions in a kissing loop complex: the dimerization initiation site of HIV-1 genomic RNA. J. Mol. Biol. 1997, 270:36-49.
130. Parada C.A., Roeder R.G. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature 1996, 384:375-378.
131. Pasquinelli A.E., Ernst R.K., Lund E., Grimm C., Zapp M.L., Rekosh D., Hammarskjöld M.L., Dahlberg J.E. The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J. 1997, 16:7500-7510.
132. Poole E., Strappe P., Mok H.P., Hicks R., Lever A.M. HIV-1 Gag-RNA interaction occurs at a perinuclear/centrosomal site; analysis by confocal microscopy and FRET. Traffic 2005, 6:741-755.
133. Poon D.T., Chertova E.N., Ott D.E. Human immunodeficiency virus type 1 preferentially encapsidates genomic RNAs that encode Pr55(Gag): functional linkage between translation and RNA packaging. Virology 2002, 293:368-378.
134. Poon D.T., Li G., Aldovini A. Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging. J. Virol. 1998, 72:1983-1993.
135. Purcell D.F., Martin M.A. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J. Virol. 1993, 67:6365-6378.
136. Purohit P., Dupont S., Stevenson M., Green M.R. Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection. RNA 2001, 7:576-584.
137. Rhodes T., Wargo H., Hu W.S. High rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication. J. Virol. 2003, 77:11193-11200.
138. Robertson-Anderson R.M., Wang J., Edgcomb S.P., Carmel A.B., Williamson J.R., Millar D.P. Single-molecule studies reveal that DEAD box protein DDX1 promotes oligomerization of HIV-1 Rev on the Rev response element. J. Mol. Biol. 2011, 410:959-971.
139. Rosen C.A., Terwilliger E., Dayton A., Sodroski J.G., Haseltine W.A. Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:2071-2075.
140. Rounseville M.P., Kumar A. Binding of a host cell nuclear protein to the stem region of human immunodeficiency virus type 1 trans-activation-responsive RNA. J. Virol. 1992, 66:1688-1694.
141. Saavedra C., Felber B., Izaurralde E. The simian retrovirus-1 constitutive transport element, unlike the HIV-1 RRE, uses factors required for cellular mRNA export. Curr. Biol. 1997, 7:619-628.
142. Sakuragi J., Sakuragi S., Shioda T. Minimal region sufficient for genome dimerization in the human immunodeficiency virus type 1 virion and its potential roles in the early stages of viral replication. J. Virol. 2007, 81:7985-7992.
143. Sherer N.M., Swanson C.M., Hué S., Roberts R.G., Bergeron J.R.C., Malim M.H. Evolution of a species-specific determinant within human CRM1 that regulates the post-transcriptional phases of HIV-1 replication. PLoS Pathog. 2011, 7:e1002395.
144. Skripkin E., Paillart J.C., Marquet R., Ehresmann B., Ehresmann C. Identification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitro. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:4945-4949.
145. Srinivasakumar N., Chazal N., Helga-Maria C., Prasad S., Hammarskjöld M.L., Rekosh D. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines. J. Virol. 1997, 71:5841-5848.
146. Sundquist W.I., Heaphy S. Evidence for interstrand quadruplex formation in the dimerization of human immunodeficiency virus 1 genomic RNA. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:3393-3397.
147. Sundquist W.I., Kräusslich H.-G. HIV-1 assembly, budding, and maturation. Cold Spring Harb. Perspect. Med. 2012, 2:a006924.
148. Swanson C.M., Puffer B.A., Ahmad K.M., Doms R.W., Malim M.H. Retroviral mRNA nuclear export elements regulate protein function and virion assembly. EMBO J. 2004, 23:2632-2640.
149. Tiley L.S., Malim M.H., Tewary H.K., Stockley P.G., Cullen B.R. Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:758-762.
150. Ward A.M., Rekosh D., Hammarskjold M.-L. Trafficking through the Rev/RRE pathway is essential for efficient inhibition of human immunodeficiency virus type 1 by an antisense RNA derived from the envelope gene. J. Virol. 2009, 83:940-952.
151. Wilkinson K.A., Gorelick R.J., Vasa S.M., Guex N., Rein A., Mathews D.H., Giddings M.C., Weeks K.M. High-throughput SHAPE analysis reveals structures in HIV-1 genomic RNA strongly conserved across distinct biological states. PLoS Biol. 2008, 6:e96.
152. Wimmer J., Fujinaga K., Taube R., Cujec T.P., Zhu Y., Peng J., Price D.H., Peterlin B.M. Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b. Virology 1999, 255:182-189.
153. Wodrich H., Schambach A., Kräusslich H.G. Multiple copies of the Mason-Pfizer monkey virus constitutive RNA transport element lead to enhanced HIV-1 Gag expression in a context-dependent manner. Nucleic Acids Res. 2000, 28:901-910.
154. Yashiroda Y., Yoshida M. Nucleo-cytoplasmic transport of proteins as a target for therapeutic drugs. Curr. Med. Chem. 2003, 10:741-748.
155. Yasuda-Inoue M., Kuroki M., Ariumi Y. Distinct DDX DEAD-box RNA helicases cooperate to modulate the HIV-1 Rev function. Biochem. Biophys. Res. Commun. 2013, 434:803-808.
156. Yedavalli V.S.R.K., Jeang K.-T. Trimethylguanosine capping selectively promotes expression of Rev-dependent HIV-1 RNAs. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:14787-14792.
157. Yedavalli V.S.R.K., Jeang K.-T. Matrin 3 is a co-factor for HIV-1 Rev in regulating post-transcriptional viral gene expression. Retrovirology 2011, 8:61.
158. Yedavalli V.S.R.K., Neuveut C., Chi Y.-H., Kleiman L., Jeang K.-T. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 2004, 119:381-392.
159. Zapp M.L., Hope T.J., Parslow T.G., Green M.R. Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:7734-7738.
160. Zhang Y., Barklis E. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation. J. Virol. 1995, 69:5716-5722.
161. Zhou X., Luo J., Mills L., Wu S., Pan T., Geng G., Zhang J., Luo H., Liu C., Zhang H. DDX5 facilitates HIV-1 replication as a cellular co-factor of Rev. PloS One 2013, 8:e65040.